ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds

June 29, 2007

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

June 22, 2007

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

Two Sarcoma Drugs Pose Classic Question: How Much PFS Does it Take to Get a Nod?

March 30, 2012